English

HERON THERAPEUTICS, INC. /DE/

EDGAR

HRTX Quarterly report (10-Q) · filed 2026-08-10

199 filing records in this dataset, filed from 1995-05-12 to 2026-08-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 20.7 million USD 2026-06-30 Source
Exact value

20721000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 188 million shares 2025-12-31 Source
Exact value

188314430 shares

Reported share-count change

23.79% · 36.2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

152127878 shares · 2024-12-31· Source
188314430 shares · 2025-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-10.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 6.62 million

Prior period

−USD 13.58 million

2024-01-01 – 2024-12-31
Current period

−USD 20.2 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-20195000 − -13580000 = -6615000 USD

-13580000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-20195000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HERON THERAPEUTICS, INC. /DE/ · 2025-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Year-over-year change in Net income: -6615000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -20195000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1752298 Filing: 000119312526073515 Input fundies:NetIncome: -13580000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1625980 Filing: 000119312526073515
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.06 million

Prior period

−USD 22.53 million

2024-01-01 – 2024-12-31
Current period

−USD 27.59 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-27591000 − -22529000 = -5062000 USD

-22529000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-27591000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HERON THERAPEUTICS, INC. /DE/ · 2025-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Year-over-year change in Operating cash flow: -5062000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -27591000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1901815 Filing: 000119312526073515 Input fundies:OperatingCashFlow: -22529000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1903566 Filing: 000119312526073515
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-81.4%

Prior period

USD 1.71 million

2024-01-01 – 2024-12-31
Current period

USD 317,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

317000 − 1706000 = -1389000 USD

1706000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
317000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · HERON THERAPEUTICS, INC. /DE/ · 2025-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Year-over-year change in Capital expenditure: -1389000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 317000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1922219 Filing: 000119312526073515 Input fundies:CapitalExpenditure: 1706000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1923958 Filing: 000119312526073515
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 197.48 million Exact value Exact value: -197484000 USD 2017-01-01 – 2017-12-31: -197484000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HERON THERAPEUTICS, INC. /DE/ · 2017-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Net Income: -197484000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -197484000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459020007973/hrtx-10k_20191231.htm#1906340 Filing: 000156459020007973 The citation records this snapshot. The page link may show a newer release later.	−USD 170.3 million Exact value Exact value: -170300000 USD 2017-01-01 – 2017-12-31: -170300000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HERON THERAPEUTICS, INC. /DE/ · 2017-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Operating Cash Flow: -170300000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -170300000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459020007973/hrtx-10k_20191231.htm#2008298 Filing: 000156459020007973 The citation records this snapshot. The page link may show a newer release later.	USD 2.55 million Exact value Exact value: 2553000 USD 2017-01-01 – 2017-12-31: 2553000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HERON THERAPEUTICS, INC. /DE/ · 2017-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Capital Expenditure: 2553000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2553000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459020007973/hrtx-10k_20191231.htm#2030720 Filing: 000156459020007973 The citation records this snapshot. The page link may show a newer release later.	−USD 172.85 million Calculation and evidence -170300000 − 2553000 USD Exact free cash flow: -172853000 USD 2017-01-01 – 2017-12-31: -170300000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2553000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HERON THERAPEUTICS, INC. /DE/ · 2017-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Free cash flow: -172853000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -170300000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459020007973/hrtx-10k_20191231.htm#2008298 Filing: 000156459020007973 Input fundies:CapitalExpenditure: 2553000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459020007973/hrtx-10k_20191231.htm#2030720 Filing: 000156459020007973 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 178.84 million Exact value Exact value: -178840000 USD 2018-01-01 – 2018-12-31: -178840000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HERON THERAPEUTICS, INC. /DE/ · 2018-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Net Income: -178840000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -178840000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459021007841/hrtx-10k_20201231.htm#2046018 Filing: 000156459021007841 The citation records this snapshot. The page link may show a newer release later.	−USD 191.81 million Exact value Exact value: -191805000 USD 2018-01-01 – 2018-12-31: -191805000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HERON THERAPEUTICS, INC. /DE/ · 2018-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Operating Cash Flow: -191805000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -191805000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459021007841/hrtx-10k_20201231.htm#2142758 Filing: 000156459021007841 The citation records this snapshot. The page link may show a newer release later.	USD 9.17 million Exact value Exact value: 9171000 USD 2018-01-01 – 2018-12-31: 9171000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HERON THERAPEUTICS, INC. /DE/ · 2018-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Capital Expenditure: 9171000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9171000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459021007841/hrtx-10k_20201231.htm#2165180 Filing: 000156459021007841 The citation records this snapshot. The page link may show a newer release later.	−USD 200.98 million Calculation and evidence -191805000 − 9171000 USD Exact free cash flow: -200976000 USD 2018-01-01 – 2018-12-31: -191805000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 9171000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HERON THERAPEUTICS, INC. /DE/ · 2018-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Free cash flow: -200976000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -191805000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459021007841/hrtx-10k_20201231.htm#2142758 Filing: 000156459021007841 Input fundies:CapitalExpenditure: 9171000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459021007841/hrtx-10k_20201231.htm#2165180 Filing: 000156459021007841 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 204.75 million Exact value Exact value: -204749000 USD 2019-01-01 – 2019-12-31: -204749000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HERON THERAPEUTICS, INC. /DE/ · 2019-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Net Income: -204749000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -204749000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1719070 Filing: 000156459022007618 The citation records this snapshot. The page link may show a newer release later.	−USD 124.58 million Exact value Exact value: -124580000 USD 2019-01-01 – 2019-12-31: -124580000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HERON THERAPEUTICS, INC. /DE/ · 2019-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Operating Cash Flow: -124580000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -124580000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1820881 Filing: 000156459022007618 The citation records this snapshot. The page link may show a newer release later.	USD 7.15 million Exact value Exact value: 7154000 USD 2019-01-01 – 2019-12-31: 7154000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HERON THERAPEUTICS, INC. /DE/ · 2019-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Capital Expenditure: 7154000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7154000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1843303 Filing: 000156459022007618 The citation records this snapshot. The page link may show a newer release later.	−USD 131.73 million Calculation and evidence -124580000 − 7154000 USD Exact free cash flow: -131734000 USD 2019-01-01 – 2019-12-31: -124580000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 7154000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HERON THERAPEUTICS, INC. /DE/ · 2019-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Free cash flow: -131734000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -124580000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1820881 Filing: 000156459022007618 Input fundies:CapitalExpenditure: 7154000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1843303 Filing: 000156459022007618 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 227.28 million Exact value Exact value: -227278000 USD 2020-01-01 – 2020-12-31: -227278000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HERON THERAPEUTICS, INC. /DE/ · 2020-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Net Income: -227278000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -227278000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1717314 Filing: 000156459022007618 The citation records this snapshot. The page link may show a newer release later.	−USD 184.82 million Exact value Exact value: -184820000 USD 2020-01-01 – 2020-12-31: -184820000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HERON THERAPEUTICS, INC. /DE/ · 2020-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Operating Cash Flow: -184820000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -184820000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1819025 Filing: 000156459022007618 The citation records this snapshot. The page link may show a newer release later.	USD 6.81 million Exact value Exact value: 6813000 USD 2020-01-01 – 2020-12-31: 6813000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HERON THERAPEUTICS, INC. /DE/ · 2020-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Capital Expenditure: 6813000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6813000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1841524 Filing: 000156459022007618 The citation records this snapshot. The page link may show a newer release later.	−USD 191.63 million Calculation and evidence -184820000 − 6813000 USD Exact free cash flow: -191633000 USD 2020-01-01 – 2020-12-31: -184820000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 6813000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HERON THERAPEUTICS, INC. /DE/ · 2020-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Free cash flow: -191633000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -184820000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1819025 Filing: 000156459022007618 Input fundies:CapitalExpenditure: 6813000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000156459022007618/hrtx-10k_20211231.htm#1841524 Filing: 000156459022007618 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 220.68 million Exact value Exact value: -220683000 USD 2021-01-01 – 2021-12-31: -220683000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HERON THERAPEUTICS, INC. /DE/ · 2021-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Net Income: -220683000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -220683000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017023010603/hrtx-20221231.htm#1660633 Filing: 000095017023010603 The citation records this snapshot. The page link may show a newer release later.	−USD 203.35 million Exact value Exact value: -203354000 USD 2021-01-01 – 2021-12-31: -203354000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HERON THERAPEUTICS, INC. /DE/ · 2021-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Operating Cash Flow: -203354000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -203354000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017023010603/hrtx-20221231.htm#1735629 Filing: 000095017023010603 The citation records this snapshot. The page link may show a newer release later.	USD 3.02 million Exact value Exact value: 3022000 USD 2021-01-01 – 2021-12-31: 3022000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HERON THERAPEUTICS, INC. /DE/ · 2021-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Capital Expenditure: 3022000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3022000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017023010603/hrtx-20221231.htm#1752871 Filing: 000095017023010603 The citation records this snapshot. The page link may show a newer release later.	−USD 206.38 million Calculation and evidence -203354000 − 3022000 USD Exact free cash flow: -206376000 USD 2021-01-01 – 2021-12-31: -203354000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3022000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HERON THERAPEUTICS, INC. /DE/ · 2021-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Free cash flow: -206376000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -203354000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017023010603/hrtx-20221231.htm#1735629 Filing: 000095017023010603 Input fundies:CapitalExpenditure: 3022000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017023010603/hrtx-20221231.htm#1752871 Filing: 000095017023010603 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 182.02 million Exact value Exact value: -182024000 USD 2022-01-01 – 2022-12-31: -182024000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HERON THERAPEUTICS, INC. /DE/ · 2022-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Net Income: -182024000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -182024000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017025028374/hrtx-20241231.htm#1672095 Filing: 000095017025028374 The citation records this snapshot. The page link may show a newer release later.	−USD 146.91 million Exact value Exact value: -146912000 USD 2022-01-01 – 2022-12-31: -146912000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HERON THERAPEUTICS, INC. /DE/ · 2022-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Operating Cash Flow: -146912000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -146912000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017025028374/hrtx-20241231.htm#1755823 Filing: 000095017025028374 The citation records this snapshot. The page link may show a newer release later.	USD 1.83 million Exact value Exact value: 1825000 USD 2022-01-01 – 2022-12-31: 1825000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HERON THERAPEUTICS, INC. /DE/ · 2022-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Capital Expenditure: 1825000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1825000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017025028374/hrtx-20241231.htm#1774776 Filing: 000095017025028374 The citation records this snapshot. The page link may show a newer release later.	−USD 148.74 million Calculation and evidence -146912000 − 1825000 USD Exact free cash flow: -148737000 USD 2022-01-01 – 2022-12-31: -146912000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1825000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HERON THERAPEUTICS, INC. /DE/ · 2022-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Free cash flow: -148737000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -146912000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017025028374/hrtx-20241231.htm#1755823 Filing: 000095017025028374 Input fundies:CapitalExpenditure: 1825000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000095017025028374/hrtx-20241231.htm#1774776 Filing: 000095017025028374 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 110.56 million Exact value Exact value: -110559000 USD 2023-01-01 – 2023-12-31: -110559000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HERON THERAPEUTICS, INC. /DE/ · 2023-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Net Income: -110559000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -110559000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1538241 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.	−USD 58.79 million Exact value Exact value: -58789000 USD 2023-01-01 – 2023-12-31: -58789000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HERON THERAPEUTICS, INC. /DE/ · 2023-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Operating Cash Flow: -58789000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -58789000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1905317 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.	USD 1.55 million Exact value Exact value: 1545000 USD 2023-01-01 – 2023-12-31: 1545000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HERON THERAPEUTICS, INC. /DE/ · 2023-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Capital Expenditure: 1545000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1545000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1925699 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.	−USD 60.33 million Calculation and evidence -58789000 − 1545000 USD Exact free cash flow: -60334000 USD 2023-01-01 – 2023-12-31: -58789000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1545000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HERON THERAPEUTICS, INC. /DE/ · 2023-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Free cash flow: -60334000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -58789000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1905317 Filing: 000119312526073515 Input fundies:CapitalExpenditure: 1545000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1925699 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 13.58 million Exact value Exact value: -13580000 USD 2024-01-01 – 2024-12-31: -13580000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HERON THERAPEUTICS, INC. /DE/ · 2024-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Net Income: -13580000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13580000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1625980 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.	−USD 22.53 million Exact value Exact value: -22529000 USD 2024-01-01 – 2024-12-31: -22529000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HERON THERAPEUTICS, INC. /DE/ · 2024-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Operating Cash Flow: -22529000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22529000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1903566 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.	USD 1.71 million Exact value Exact value: 1706000 USD 2024-01-01 – 2024-12-31: 1706000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HERON THERAPEUTICS, INC. /DE/ · 2024-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Capital Expenditure: 1706000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1706000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1923958 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.	−USD 24.24 million Calculation and evidence -22529000 − 1706000 USD Exact free cash flow: -24235000 USD 2024-01-01 – 2024-12-31: -22529000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1706000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HERON THERAPEUTICS, INC. /DE/ · 2024-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Free cash flow: -24235000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22529000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1903566 Filing: 000119312526073515 Input fundies:CapitalExpenditure: 1706000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1923958 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 20.2 million Exact value Exact value: -20195000 USD 2025-01-01 – 2025-12-31: -20195000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HERON THERAPEUTICS, INC. /DE/ · 2025-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Net Income: -20195000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20195000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1752298 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.	−USD 27.59 million Exact value Exact value: -27591000 USD 2025-01-01 – 2025-12-31: -27591000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HERON THERAPEUTICS, INC. /DE/ · 2025-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Operating Cash Flow: -27591000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27591000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1901815 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.	USD 317,000 Exact value Exact value: 317000 USD 2025-01-01 – 2025-12-31: 317000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HERON THERAPEUTICS, INC. /DE/ · 2025-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Capital Expenditure: 317000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 317000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1922219 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.	−USD 27.91 million Calculation and evidence -27591000 − 317000 USD Exact free cash flow: -27908000 USD 2025-01-01 – 2025-12-31: -27591000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 317000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HERON THERAPEUTICS, INC. /DE/ · 2025-12-31 HERON THERAPEUTICS, INC. /DE/ (edgar:818033) Free cash flow: -27908000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:40:37Z Snapshot: 257f909830119c8baaf94998e5bf30a895281f3473ac957919c6181edc358ecf Dimensions: Consolidated View: https://fundies.io/companies/edgar/818033?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27591000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1901815 Filing: 000119312526073515 Input fundies:CapitalExpenditure: 317000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/hrtx-20251231.htm#1922219 Filing: 000119312526073515 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

199 filings · 3,750 latest values · 3,750 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000818033, 818033, HRTX, edgar:818033, hrtx

Also known as ADVANCED POLYMER SYSTEMS INC /DE/, AP PHARMA INC /DE/, HERON THERAPEUTICS, INC, HERON THERAPEUTICS, INC., HERON THERAPEUTICS, INC. /DE/, Heron Therapeutics, Inc.

HERON THERAPEUTICS, INC. /DE/

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation